Research Article

Predictors for Early Identification of Hepatitis C Virus Infection

Table 1

Comparison of demographic characteristics and clinical measurements in the HCV-infected group and in the negative control group.

VariableHCV-infected group
( = 144)
Negative control group
( = 168)
-test
ANCOVA

Gender (%)
 Male83 (57.6)38 (22.6)
 Female61 (42.4)130 (77.4)<0.001
Age mean (sd)39.3 ± 10.837.4 ± 7.3 0.071
WBC (×103l)6.8 ± 1.96.0 ± 1.7<0.0010.006
RBC (×106l)4.9 ± 0.74.5 ± 0.5<0.0010.024
HB (g/dl)14.7 ± 1.513.4 ± 1.8<0.001<0.001
HCT (%)43.0 ± 3.939.8 ± 4.4<0.0010.001
MCV (fl)89.1 ± 8.088.1 ± 6.30.2430.122
MCH (pg)30.5 ± 3.129.6 ± 2.80.0080.030
MCHC (g/dl)34.2 ± 1.033.5 ± 1.3<0.0010.005
PLT (×103)222.3 ± 58.8270.5 ± 61.8<0.001<0.001
NEU (%)56.4 ± 9.058.3 ± 8.20.052<0.001
LYM (%)34.0 ± 8.233.1 ± 7.70.270 0.648
MONO (%)6.6 ± 1.85.7 ± 1.4<0.001<0.001
EOS (%)2.5 ± 1.62.4 ± 1.70.6300.174
BAS (%)0.5 ± 0.30.5 ± 0.30.1400.230
RDW-SD (fl)41.8 ± 2.942.6 ± 2.90.0130.055
RDW-CV (%)13.3 ± 1.513.6 ± 1.50.0400.034
PDW (fl)13.2 ± 2.012.1 ± 1.9<0.001<0.001
MPV (fl)10.8 ± 0.810.5 ± 0.9<0.0010.001
P-LCR (%)31.7 ± 6.228.5 ± 6.4<0.001<0.001
PCT (%)0.2 ± 0.10.3 ± 0.1<0.001<0.001
NEUT (×103l)3.9 ± 1.43.6 ± 1.30.0340.090
LYMPH (×103l)2.3 ± 0.71.9 ± 0.6<0.0010.004
MONO (×103l)0.4 ± 0.10.3 ± 0.1<0.001<0.001
EOS (×103l)0.2 ± 0.10.1 ± 0.10.0830.561
BAS (×103l)0.03 ± 0.020.03 ± 0.020.4630.789
TPO (pg/ml)74.4 ± 66.342.0 ± 37.9<0.001<0.001
ALT (IU/L)35.5 ± 45.023.3 ± 29.50.0060.339

HCV: hepatitis C virus; ANCOVA: analysis of covariance; WBC: white blood cell count; RBC: red blood cell count; Hb: haemoglobin; HCT: haematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular haemoglobin; MCHC: mean corpuscular haemoglobin concentration; RDW: RBC distribution width; PLT: platelet count; PCT: plateletcrit; PDW: platelet distribution width; MPV: mean platelet volume; P-LCR: platelet-large cell ratio; NEU: neutrophil; LYM: lymphocyte; MON: monocyte; EOS: eosinophil; BAS: basophil; TPO: thrombopoietin; ALT: alanine aminotransferase.
Significance level: < 0.05.
Age- and gender-adjusted value.